Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2015

Feb 3, 2015

34301_dirs_2015-02-03_56a4c117-1a38-407e-9412-cc06f901d184.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-01-30

Reporting Person: SHIRAHAMA NORIO SEIJIRO (President - Asia Pacific)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-01-30 Employee Stock Option $0.48 A 80000 Acquired 2025-01-30 Common Stock (80000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 48659 Direct

Footnotes

F1: The Employee Stock options vest 1/48th each month from date of grant, subject to remaining an employee of the Company.